Several studies have shown that in patients with NAFLD, serum resistin levels are correlated with insulin resistance and the severity of steatosis, inflammation, and fibrosis [6,7,8]. This evidence concerns the gene RETN and metabolic dysfunction-associated steatotic liver disease.